AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 152 filers reported holding AERIE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,508,000 | +74.8% | 231,847 | -13.3% | 0.00% | – |
| Q2 2022 | $2,007,000 | -17.6% | 267,565 | 0.0% | 0.00% | – |
| Q1 2022 | $2,435,000 | +67.4% | 267,565 | +29.1% | 0.00% | – |
| Q4 2021 | $1,455,000 | +248.1% | 207,269 | +568.1% | 0.00% | – |
| Q4 2020 | $418,000 | -95.8% | 31,025 | -96.3% | 0.00% | -100.0% |
| Q3 2020 | $9,958,000 | -39.2% | 845,959 | -23.8% | 0.00% | -50.0% |
| Q2 2020 | $16,380,000 | -82.0% | 1,109,758 | -83.5% | 0.00% | -83.3% |
| Q1 2020 | $90,939,000 | -39.7% | 6,736,222 | +7.9% | 0.02% | -25.0% |
| Q4 2019 | $150,846,000 | +23.2% | 6,241,041 | -2.1% | 0.03% | +14.3% |
| Q3 2019 | $122,475,000 | -34.8% | 6,372,285 | +0.2% | 0.03% | -33.3% |
| Q2 2019 | $187,937,000 | -37.4% | 6,359,926 | +0.7% | 0.04% | -38.2% |
| Q1 2019 | $300,132,000 | +33.0% | 6,318,560 | +1.1% | 0.07% | +21.4% |
| Q4 2018 | $225,723,000 | -36.8% | 6,252,699 | +7.7% | 0.06% | -25.3% |
| Q3 2018 | $357,220,000 | -0.7% | 5,803,747 | +9.0% | 0.08% | -6.2% |
| Q2 2018 | $359,724,000 | +23.5% | 5,325,289 | -0.8% | 0.08% | +21.2% |
| Q1 2018 | $291,287,000 | -3.7% | 5,369,351 | +6.1% | 0.07% | -1.5% |
| Q4 2017 | $302,422,000 | +27.8% | 5,061,463 | +3.9% | 0.07% | +24.1% |
| Q3 2017 | $236,692,000 | +35.7% | 4,870,216 | +46.8% | 0.05% | +31.7% |
| Q2 2017 | $174,365,000 | +32.8% | 3,318,106 | +14.6% | 0.04% | +28.1% |
| Q1 2017 | $131,330,000 | +19.4% | 2,895,926 | -0.0% | 0.03% | +14.3% |
| Q4 2016 | $110,007,000 | -10.9% | 2,897,135 | -11.1% | 0.03% | -9.7% |
| Q3 2016 | $123,401,000 | +118.5% | 3,260,078 | +1.6% | 0.03% | +106.7% |
| Q2 2016 | $56,486,000 | +52.9% | 3,209,396 | +5.6% | 0.02% | +50.0% |
| Q1 2016 | $36,942,000 | -56.7% | 3,037,983 | -13.4% | 0.01% | -54.5% |
| Q4 2015 | $85,388,000 | +40.7% | 3,506,646 | +2.5% | 0.02% | +29.4% |
| Q3 2015 | $60,675,000 | +2.2% | 3,420,240 | +1.6% | 0.02% | +13.3% |
| Q2 2015 | $59,389,000 | -43.7% | 3,364,832 | -0.0% | 0.02% | -44.4% |
| Q1 2015 | $105,494,000 | +8.7% | 3,366,106 | +1.3% | 0.03% | +3.8% |
| Q4 2014 | $97,032,000 | +41.9% | 3,324,170 | +0.6% | 0.03% | +36.8% |
| Q3 2014 | $68,366,000 | +12.2% | 3,304,380 | +34.4% | 0.02% | +18.8% |
| Q2 2014 | $60,915,000 | +50.0% | 2,459,199 | +28.3% | 0.02% | +45.5% |
| Q1 2014 | $40,616,000 | +36.7% | 1,916,748 | +15.8% | 0.01% | +22.2% |
| Q4 2013 | $29,720,000 | – | 1,654,803 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|